William Aliski Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for William Aliski.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of William Aliski. William Aliski is Director in APPLIED GENETIC TECHNOLOGIES CORP ($AGTC) and Director in X4 Pharmaceuticals, Inc ($ASNS) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE).

Latest Insider Trading Transactions of William Aliski

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AGTC, RARE, ASNS

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 02 2021	ASNS	X4 Pharmaceuticals ...	Aliski William	Director	Option Exercise	A	9.50	6,000	57,000	6,000
Feb 23 2021	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	M	97.85	7,500	733,875	0
Feb 23 2021	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Gift	G	0.00	1,000	0	64,704	65.7 K to 64.7 K (-1.52 %)
Feb 23 2021	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	149.01	7,500	1,117,575	65,704	73.2 K to 65.7 K (-10.25 %)
Feb 23 2021	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Buy	M	97.85	7,500	733,875	73,204	65.7 K to 73.2 K (+11.41 %)
Dec 18 2020	AGTC	APPLIED GENETIC TE ...	Aliski William	Director	Option Exercise	A	4.72	12,000	56,640	12,000
Aug 25 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	M	58.74	5,000	293,700	0
Aug 25 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	86.57	5,000	432,850	57,018	62 K to 57 K (-8.06 %)
Aug 25 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Buy	M	58.74	5,000	293,700	62,018	57 K to 62 K (+8.77 %)
Jun 30 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	A	76.58	4,250	325,465	4,250
Jun 30 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Grant	A	0.00	2,550	0	57,018	54.5 K to 57 K (+4.68 %)
Jun 11 2020	ASNS	X4 Pharmaceuticals ...	Aliski William	Director	Option Exercise	A	8.69	3,427	29,781	3,427
Jun 03 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	74.02	20,000	1,480,322	70,350	90.4 K to 70.4 K (-22.14 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	M	40.37	7,500	302,775	0
May 20 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	74.65	7,500	559,875	47,924	55.4 K to 47.9 K (-13.53 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Buy	M	40.37	7,500	302,775	55,424	47.9 K to 55.4 K (+15.65 %)
Dec 06 2019	AGTC	APPLIED GENETIC TE ...	Aliski William	Director	Option Exercise	A	3.02	10,000	30,200	10,000
Sep 20 2019	ASNS	X4 Pharmaceuticals ...	Aliski William	Director	Option Exercise	A	14.04	6,854	96,230	6,854
Sep 20 2019	ASNS	X4 Pharmaceuticals ...	Aliski William	Director	Option Exercise	A	14.04	6,854	96,230	6,854
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Grant	A	0.00	3,000	0	47,924	44.9 K to 47.9 K (+6.68 %)
Dec 18 2018	AGTC	APPLIED GENETIC TE ...	Aliski William	Director	Buy	P	3.24	500	1,620	8,500	8 K to 8.5 K (+6.25 %)
Dec 18 2018	AGTC	APPLIED GENETIC TE ...	Aliski William	Director	Buy	P	3.25	4,300	13,975	8,000	3.7 K to 8 K (+116.22 %)
Dec 18 2018	AGTC	APPLIED GENETIC TE ...	Aliski William	Director	Buy	P	3.24	1,200	3,882	3,700	2.5 K to 3.7 K (+48.00 %)
Dec 07 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	49.69	6,000	298,140	90,350	96.4 K to 90.4 K (-6.23 %)
Nov 19 2018	AGTC	APPLIED GENETIC TE ...	Aliski William	Director	Option Exercise	A	6.90	10,000	69,000	10,000
Nov 08 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	55.67	6,000	334,020	96,350	102.4 K to 96.4 K (-5.86 %)
Oct 09 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	C	0.00	266,343	0	0
Oct 09 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	73.38	6,000	440,280	102,350	108.4 K to 102.4 K (-5.54 %)
Oct 09 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	53.97	650	35,081	108,350	109 K to 108.4 K (-0.60 %)
Oct 09 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	122.58	400	49,032	109,000	109.4 K to 109 K (-0.37 %)
Oct 09 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	85.94	2,000	171,880	109,400	111.4 K to 109.4 K (-1.80 %)
Oct 09 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	68.65	10,500	720,825	111,400	121.9 K to 111.4 K (-8.61 %)
Oct 09 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Buy	C	0.00	84,970	0	121,900	36.9 K to 121.9 K (+230.08 %)
Sep 24 2018	AGTC	APPLIED GENETIC TE ...	Aliski William	Director	Option Exercise	A	4.40	25,000	110,000	25,000
Aug 08 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	76.66	3,750	287,475	72,610	76.4 K to 72.6 K (-4.91 %)
Jun 20 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	A	80.69	5,000	403,450	5,000
Jun 20 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Grant	A	0.00	3,000	0	76,360	73.4 K to 76.4 K (+4.09 %)
Jan 25 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	M	21.00	11,500	241,500	0
Jan 25 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Buy	M	21.00	11,500	241,500	73,360	61.9 K to 73.4 K (+18.59 %)
Jun 22 2017	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	A	65.66	3,750	246,225	3,750
Jun 22 2017	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Grant	A	0.00	1,875	0	61,860	60 K to 61.9 K (+3.13 %)
Dec 05 2016	RARE	Ultragenyx Pharmac ...	Aliski William		Option Exercise	M	21.00	6,000	126,000	11,500
Dec 05 2016	RARE	Ultragenyx Pharmac ...	Aliski William		Sell	S	78.70	2,000	157,400	59,985	62 K to 60 K (-3.23 %)
Dec 05 2016	RARE	Ultragenyx Pharmac ...	Aliski William		Sell	S	77.94	4,000	311,760	61,985	66 K to 62 K (-6.06 %)
Dec 05 2016	RARE	Ultragenyx Pharmac ...	Aliski William		Buy	M	21.00	6,000	126,000	65,985	60 K to 66 K (+10.00 %)
Jun 14 2016	RARE	Ultragenyx Pharmac ...	Aliski William		Option Exercise	A	65.85	3,750	246,938	3,750
Jun 14 2016	RARE	Ultragenyx Pharmac ...	Aliski William		Grant	A	0.00	1,875	0	59,985	58.1 K to 60 K (+3.23 %)
Jun 22 2015	RARE	Ultragenyx Pharmac ...	Aliski William		Option Exercise	A	97.85	7,500	733,875	7,500
Dec 08 2014	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	42.46	3,109	132,013	60,010	63.1 K to 60 K (-4.93 %)
Dec 08 2014	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	41.83	2,891	120,929	63,119	66 K to 63.1 K (-4.38 %)
Oct 22 2014	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	M	3.01	29,108	87,615	0
Oct 22 2014	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Buy	M	3.01	29,108	87,615	66,010	36.9 K to 66 K (+78.88 %)
Jul 17 2014	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	A	40.37	7,500	302,775	7,500
Feb 07 2014	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	J	3.01	29,108	87,615	0
Feb 07 2014	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	J	0.96	91,241	87,500	0
Feb 03 2014	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	A	21.00	17,500	367,500	17,500
Feb 03 2014	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Buy	P	21.00	5,000	105,000	36,903	31.9 K to 36.9 K (+15.67 %)

Page: 1